Advances in molecular and structural and functional neuroimaging are
rapidly expanding the complexity of neurobiological understanding of
Parkinson’s disease (PD). This review article begins with an
introduction to PD neurobiology as a foundation for interpreting neuroimaging
findings that may further lead to more integrated and comprehensive
understanding of PD. Diverse areas of PD neuroimaging are then reviewed and
summarized, including positron emission tomography, single photon emission
computed tomography, magnetic resonance spectroscopy and imaging, transcranial
sonography, magnetoencephalography, and multimodal imaging, with focus on human
studies published over the last five years. These included studies on
differential diagnosis, co-morbidity, genetic and prodromal PD, and treatments
from L-DOPA to brain stimulation approaches, transplantation and gene therapies.
Overall, neuroimaging has shown that PD is a neurodegenerative disorder
involving many neurotransmitters, brain regions, structural and functional
connections, and neurocognitive systems. A broad neurobiological understanding
of PD will be essential for translational efforts to develop better treatments
and preventive strategies. Many questions remain and we conclude with some
suggestions for future directions of neuroimaging of PD.